George Kumar, Senior Director at AstraZeneca, shared a post LinkedIn about a recent article by Arthur G. Cosby et al, published in British Journal of Cancer:
“The Cancer Gap America Isn’t Talking About. Where You Live Determines Whether You Benefit.
From Cancer Progress America’s cancer death rate dropped 32% between 1991 and 2019. But that progress wasn’t shared equally.
A new county-level analysis of over 21 million cancer deaths reveals a stark geographic and economic divide in who benefited most:
- Coastal, urban, higher-income counties saw the greatest reductions in cancer mortality
- High-income counties were first to improve — and improved fastest
- County income and urbanization were the strongest predictors of progress
- Black residents and education levels were less predictive than geography and wealth
The map of cancer progress looks a lot like the map of economic privilege.
Figure Courtesy: British Journal of Cancer
Viswadeep Lebakula: Oak Ridge National Laboratory, Oak Ridge, TN, USA”
Title: Who is benefiting from the dramatic decline in U.S. cancer mortality? Place-based evidence of disparities in rates of improvement
Authors: Arthur G. Cosby, Viswadeep Lebakula, Karissa Bergene, Gina Rico Mendez, Mackenzie Bumgarner, Alina Peluso
Read the Full Article on British Journal of Cancer.
More posts featuring George Kumar
